BIOMAT Database Logo BIOMAT Database Logo

Mechanism-based thrombin inhibitors: design, synthesis, and molecular docking of a new selective 2-oxo-2H-1-benzopyran derivative. 2007

Raphaël Frédérick, and Séverine Robert, and Caroline Charlier, and Johan Wouters, and Bernard Masereel, and Lionel Pochet
Department of Pharmacy, University of Namur, FUNDP, 61, Rue de Bruxelles, B-5000 Namur, Belgium. raphael.frederick@gmail.com

New 2-oxo-2H-1-benzopyran derivatives were prepared to optimize 2a,b, initially developed as mechanism-based alpha-chymotrypsin (alpha-CT) inhibitors, into potent and selective thrombin (THR) inhibitors. From this study, 22, characterized by a 2-(N-ethyl-2'-oxoacetamide)-5'-chlorophenyl ester side chain, was shown to be a good THR inhibitor (ki/KI = 3455 M(-1) x s(-1)), displaying an excellent selectivity profile against other serine proteases such as factor Xa, trypsin, and alpha-CT. Docking analysis of this compound into the different protein structures revealed the molecular basis responsible for its potency and selectivity.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D001578 Benzopyrans Compounds with a core of fused benzo-pyran rings. Benzopyran,Chromene,Chromenes
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013917 Thrombin An enzyme formed from PROTHROMBIN that converts FIBRINOGEN to FIBRIN. Thrombase,Thrombin JMI,Thrombin-JMI,Thrombinar,Thrombostat,alpha-Thrombin,beta,gamma-Thrombin,beta-Thrombin,gamma-Thrombin,JMI, Thrombin
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Raphaël Frédérick, and Séverine Robert, and Caroline Charlier, and Johan Wouters, and Bernard Masereel, and Lionel Pochet
7-Hydroxy-6-methoxy-3-[(2-oxo-2H-1-benzopyran-7-yl)oxy]-2H-1-benzopyran-2-one.
February 2006, Acta crystallographica. Section C, Crystal structure communications,
Raphaël Frédérick, and Séverine Robert, and Caroline Charlier, and Johan Wouters, and Bernard Masereel, and Lionel Pochet
Synthesis and in vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.
February 2006, European journal of medicinal chemistry,
Raphaël Frédérick, and Séverine Robert, and Caroline Charlier, and Johan Wouters, and Bernard Masereel, and Lionel Pochet
Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.
August 2010, Bioorganic & medicinal chemistry letters,
Raphaël Frédérick, and Séverine Robert, and Caroline Charlier, and Johan Wouters, and Bernard Masereel, and Lionel Pochet
Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of N,N'-bis[2-oxo-2H-benzopyran]-3-carboxamides.
August 2006, Bioorganic & medicinal chemistry letters,
Raphaël Frédérick, and Séverine Robert, and Caroline Charlier, and Johan Wouters, and Bernard Masereel, and Lionel Pochet
catena-Poly[[[aqua(7-hydroxy-2H-1-benzopyran-2-one)sodium]-di-μ-aqua] 2-oxo-2H-1-benzopyran-7-olate monohydrate].
June 2010, Acta crystallographica. Section E, Structure reports online,
Raphaël Frédérick, and Séverine Robert, and Caroline Charlier, and Johan Wouters, and Bernard Masereel, and Lionel Pochet
Synthesis and anti-inflammatory activity of N-substituted 2-oxo-2H-1-benzopyran-3-carboxamides and their 2-iminoanalogues.
November 1999, European journal of medicinal chemistry,
Raphaël Frédérick, and Séverine Robert, and Caroline Charlier, and Johan Wouters, and Bernard Masereel, and Lionel Pochet
Design, synthesis, biological evaluation, and molecular docking of novel benzopyran and phenylpyrazole derivatives as Akt inhibitors.
June 2015, Chemical biology & drug design,
Raphaël Frédérick, and Séverine Robert, and Caroline Charlier, and Johan Wouters, and Bernard Masereel, and Lionel Pochet
Design, synthesis and molecular modelling of 1-amidinopiperidine thrombin inhibitors.
April 2007, Die Pharmazie,
Raphaël Frédérick, and Séverine Robert, and Caroline Charlier, and Johan Wouters, and Bernard Masereel, and Lionel Pochet
Synthesis and insecticidal activity of new 4-hydroxy-2H-1-benzopyran-2-one derivatives.
December 2009, Applied biochemistry and biotechnology,
Raphaël Frédérick, and Séverine Robert, and Caroline Charlier, and Johan Wouters, and Bernard Masereel, and Lionel Pochet
Studies of the benzopyran class of selective COX-2 inhibitors using 3D-QSAR and molecular docking.
December 2018, Archives of pharmacal research,
Copied contents to your clipboard!